HOUSE DOCKET, NO. 2693 FILED ON: 1/21/2011
HOUSE . . . . . . . . . . . . . . . No. 3163
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Thomas A. Golden, Jr.
_______________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the passage of the accompanying:
An Act relative to optometrists scope of practice.
_______________
PETITION OF:
Name: | District/Address: |
Thomas A. Golden, Jr. | 16th Middlesex |
Jennifer E. Benson | 37th Middlesex |
William N. Brownsberger |
[District]
|
Angelo J. Puppolo, Jr. | 12th Hampden |
David B. Sullivan | 6th Bristol |
Denise Provost | 27th Middlesex |
Chris Walsh | 6th Middlesex |
Christine E. Canavan | 10th Plymouth |
David M. Nangle | 17th Middlesex |
Kevin J. Murphy | 18th Middlesex |
HOUSE DOCKET, NO. 2693 FILED ON: 1/21/2011
HOUSE . . . . . . . . . . . . . . . No. 3163
By Mr. Golden of Lowell, a petition (accompanied by bill, House, No. 3163) of Thomas A. Golden, Jr. and others relative to the scope of practice by optometrists. Public Health. |
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE
HOUSE
, NO. 2060 OF 2009-2010.]
The Commonwealth of Massachusetts
An Act relative to optometrists scope of practice.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Section 66B of Chapter 112 of the General Laws, as appearing in the 2008 Official Edition, is hereby amended by inserting, in the first paragraph, after the words “except for those listed in schedule” and inserting after the following new words: “III through”
SECTION 2. Section 66B of Chapter 112 of the General Laws, as appearing in the 2008 Official Edition, is hereby amended by striking the last sentence in its entirety and inserting the following new sentence:
“For the purposes of this section and section 68B, the term “therapeutic pharmaceutical agents” shall mean those pharmaceutical agents required for the diagnosis, prevention, management or treatment of abnormal ocular conditions or diseases.”
